Neurological Immune-Related Adverse Events of IpilimumabPract Neurol 13:278-280, Bot, I.,et al, 2013
Neurotoxicity After Treatment with Muromonab-CD3NEJM 323:487-488, Richards,J.M.,et al, 1990